News
Zavation News and Announcements

Zavation, a Gemspring Capital Portfolio Company, Acquires CoreLink
Zavation Medical Products, LLC (“Zavation”), an innovative designer and manufacturer of spinal implant, interventional spine and biologics products and a portfolio company of Gemspring Capital (“Gemspring”), today announced that it has acquired CoreLink, LLC (“CoreLink”), a leading, vertically-integrated provider of spinal implant and instrumentation systems, from The Stephens Group, LLC.

Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™”
Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the results of its novel LABYRINTH™ technology in an In-Vitro and In-Vivo research project.

Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand™ Lateral Cage as an addition to its eZspand™ Interbody System
Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the FDA 510K Clearance of eZspand™ Lateral, an expandable lumbar interbody fusion device.

Gemspring Acquires Zavation Medical Products
Gemspring Capital Management LLC (“Gemspring”), a middle-market private equity firm, is pleased to announce that an affiliate has acquired a majority interest in Zavation Medical Products, LLC (“Zavation” or the “Company”).